Psyched: Canada Allows Psilocybin Use For Healthcare Pros, UK Begins DMT Trials, Cybin To Purchase Adelia

Canada Allows Professionals In Training To Use Psilocybin

The Canadian Health Minister Patty Hajdu has allowed 17 healthcare professionals to possess and use psilocybin to conduct professional training in psilocybin-assisted therapy.

The decision, announced Tuesday, marks the latest step in Canada’s path towards the legalization of psilocybin.

Since August 2020, Canada’s Health Minister has granted 14 exemptions to access psilocybin therapy, mainly for patients dealing with end-of-life distress.

“Health Canada now rightfully acknowledges that clinician experience with psychedelic medicines is an important part of their training. Therapists having psychedelic experience are able to more deeply empathize with patients and understand their experience,” said Bruce Tobin, founder and Board Chair of TheraPsil, a nonprofit working for patient access to psilocybin in Canada.

The UK To Begin First-Ever Clinical Trials On DMT For Depression

The Imperial College of London, in partnership with neuropharmaceutical research company Small Pharma, have been granted approval from UK authorities to begin clinical trials on the hallucinogenic drug DMT for the treatment of depression.

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) gave the green light to begin the trials, which are expected to start in January 2021, The Guardian reported.

The trials will mark the first time that DMT is studied in the treatment of clinical depression. The institutions stated that the …

Full story available on Benzinga.com

More Psyched: Canada Allows Psilocybin Use For Healthcare Pros, UK Begins DMT Trials, Cybin To Purchase Adelia